Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection Read more about Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection
Novel INXN-4001 Triple Effector Plasmid in Heart Failure Read more about Novel INXN-4001 Triple Effector Plasmid in Heart Failure
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) Read more about Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries Read more about Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis Read more about A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) Read more about A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)
Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery Read more about Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery
To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection Read more about To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer Read more about Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer